Oscar Health Free Cash Flow (FCF) History (OSCR)
Oscar Health reported $1.06B in free cash flow for fiscal 2025, an increase of 11.38% from the previous fiscal year, with a free cash flow margin of 3701.89%.
View full Oscar Health company overviewOscar Health free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.06B | $108.2M | +11.38% | +3701.89% |
| 2024 | 2024-12-31 | $950.3M | $1.25B | — | +4618.47% |
| 2023 | 2023-12-31 | −$297.7M | −$649.1M | — | −1394.35% |
| 2022 | 2022-12-31 | $351.3M | $559.0M | — | +541.13% |
| 2021 | 2021-12-31 | −$207.6M | −$416.3M | — | −3849.28% |
| 2020 | 2020-12-31 | $208.7M | $400.1M | — | — |
| 2019 | 2019-12-31 | −$191.4M | — | — | −39.20% |
Oscar Health quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.08B | $1.58B | +316.29% | +34135.90% |
| Q1 2026 | 2026-03-31 | $2.61B | $1.74B | +200.19% | +45648.58% |
| Q4 2025 | 2025-12-31 | $662.8M | $322.8M | +94.95% | +7393.65% |
| Q3 2025 | 2025-09-30 | −$973.7M | −$466.0M | — | −11063.12% |
| Q2 2025 | 2025-06-30 | $499.8M | $10.2M | +2.08% | +7692.63% |
| Q1 2025 | 2025-03-31 | $869.5M | $241.1M | +38.37% | +20081.20% |
| Q4 2024 | 2024-12-31 | $340.0M | $49.2M | +16.93% | +7065.69% |
| Q3 2024 | 2024-09-30 | −$507.7M | $648.0M | — | −10363.48% |
| Q2 2024 | 2024-06-30 | $489.6M | $329.7M | +206.17% | +9359.38% |
| Q1 2024 | 2024-03-31 | $628.4M | $221.1M | +54.27% | +11153.94% |
| Q4 2023 | 2023-12-31 | $290.8M | $146.5M | +101.55% | +5079.77% |
| Q3 2023 | 2023-09-30 | −$1.16B | −$597.8M | — | −20858.06% |
| Q2 2023 | 2023-06-30 | $159.9M | −$48.5M | −23.29% | +3144.68% |
| Q1 2023 | 2023-03-31 | $407.3M | −$149.3M | −26.82% | +8141.83% |
| Q4 2022 | 2022-12-31 | $144.3M | $117.0M | +428.96% | +2198.81% |
| Q3 2022 | 2022-09-30 | −$558.0M | $37.4M | — | −2873.07% |
| Q2 2022 | 2022-06-30 | $208.4M | $159.1M | +322.06% | +1019.21% |
| Q1 2022 | 2022-03-31 | $556.6M | $245.5M | +78.91% | +3009.80% |
| Q4 2021 | 2021-12-31 | $27.3M | −$58.4M | −68.16% | +865.26% |
| Q3 2021 | 2021-09-30 | −$595.4M | −$373.6M | — | −38462.53% |
| Q2 2021 | 2021-06-30 | $49.4M | −$193.0M | −79.63% | +13991.22% |
| Q1 2021 | 2021-03-31 | $311.1M | $208.7M | +203.90% | +91234.02% |
| Q4 2020 | 2020-12-31 | $85.7M | — | — | — |
| Q3 2020 | 2020-09-30 | −$221.8M | — | — | −218.05% |
| Q2 2020 | 2020-06-30 | $242.4M | — | — | +210.22% |
| Q1 2020 | 2020-03-31 | $102.4M | — | — | +116.20% |
Oscar Health free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $208.7M to $1.06B, a compound annual growth rate of 38.37%. Oscar Health's latest reported quarter, Q2 2026, generated $2.08B in free cash flow, an increase of 316.29% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Oscar Health filings at SEC.gov ↗